Cite
Chan E, Duckworth LV, Alkhasawneh A, et al. Discordant HER2 expression and response to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinoma. J Gastrointest Oncol. 2016;7(2):173-80doi: 10.3978/j.issn.2078-6891.2015.071.
Chan, E., Duckworth, L. V., Alkhasawneh, A., Toro, T. Z., Lu, X., Ben-David, K., Hughes, S. J., Rossidis, G., Zlotecki, R., Lightsey, J., Daily, K. C., Dang, L., Allegra, C. J., King, B., & George, T. J. (2016). Discordant HER2 expression and response to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinoma. Journal of gastrointestinal oncology, 7(2), 173-80. https://doi.org/10.3978/j.issn.2078-6891.2015.071
Chan, Ellie, et al. "Discordant HER2 expression and response to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinoma." Journal of gastrointestinal oncology vol. 7,2 (2016): 173-80. doi: https://doi.org/10.3978/j.issn.2078-6891.2015.071
Chan E, Duckworth LV, Alkhasawneh A, Toro TZ, Lu X, Ben-David K, Hughes SJ, Rossidis G, Zlotecki R, Lightsey J, Daily KC, Dang L, Allegra CJ, King B, George TJ. Discordant HER2 expression and response to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinoma. J Gastrointest Oncol. 2016 Apr;7(2):173-80. doi: 10.3978/j.issn.2078-6891.2015.071. PMID: 27034783; PMCID: PMC4783750.
Copy
Download .nbib